The effects of heparin coated circuits on pulmonary injury -: A clinical study

被引:0
|
作者
Kazaz, H [1 ]
Oto, Ö [1 ]
Sariosmanoglu, N [1 ]
Hazan, E [1 ]
机构
[1] Dokuz Eylul Univ, Dept Thorac & Cardiovasc Surg, Izmir, Turkey
来源
JOURNAL OF CARDIOVASCULAR SURGERY | 2003年 / 44卷 / 05期
关键词
cardiopulmonary bypass; coated materials; biocompatible; heparin; complement activation; lung; physiopathology;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim Heparin-coated circuits have dramatic effects on the coagulation cascade, but their role on complement activation has not been clearly defined. in this clinical study the effect of heparin-coated circuits on static lung compliance and pulmonary vascular resistance is described. Methods. Thirty patients were randomly divided into two groups: with either a heparin-coated circuit or an identical but non-coated circuit control group. in the heparin-coated group, all the blood contacting surfaces were treated with immobilized heparin (Duraflo II.) Results. Early postoperative pulmonary function is determined with measurements of static lung compliance, pulmonary vascular resistance and arterial blood gases. Static lung compliance was significantly better in the heparin coated (HC) group in the early postoperative period (p=0.001). Pulmonary vascular resistance was significantly lower in the heparin-coated (HC) group in the early postoperative period (p=0.001). Conclusion. We believe that the method of heparin binding may play a role in its diminished effect on complement activation, but the general augmentation of the circuit's biocompatibility may explain its beneficial effect on pulmonary vascular resistance and static lung compliance.
引用
收藏
页码:611 / 615
页数:5
相关论文
共 50 条
  • [21] Heparin-coated circuits: A new perspective - The boundary layer
    Poullis, M
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 1999, 13 (04) : 508 - 509
  • [22] BIOCOMPATIBILITY OF HEPARIN-COATED CIRCUITS USED IN CARDIOPULMONARY BYPASS
    PEKNA, M
    BOROWIEC, J
    FAGERHOL, MK
    VENGE, P
    THELIN, S
    SCANDINAVIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1994, 28 (01): : 5 - 11
  • [23] Specific complement inhibition with heparin-coated extracorporeal circuits
    Velthuis, HT
    Jansen, PGM
    Hack, CE
    Eijsman, L
    Wildevuur, CRH
    ANNALS OF THORACIC SURGERY, 1996, 61 (04): : 1153 - 1157
  • [24] Comparative studies of glycoprotein Ib in heparin coated and nonheparin coated extracorporeal circulation circuits
    Hioki, Iwao
    Yada, Isao
    Nishikawa, Masakatsu
    Shomura, Yu
    Cruz, Bayardo Pagoada
    Onoda, Koji
    Tani, Kazuhiro
    Shimono, Takatsugu
    Shinpo, Hideto
    ASAIO Journal, 44 (05):
  • [25] Comparative studies of glycoprotein Ib in heparin coated and nonheparin coated extracorporeal circulation circuits
    Hioki, I
    Yada, I
    Nishikawa, M
    Shomura, Y
    Cruz, BP
    Onoda, K
    Tani, K
    Shimono, T
    Shinpo, H
    ASAIO JOURNAL, 1998, 44 (05) : M397 - M400
  • [26] Clinical evaluation of Duraflo(R) II heparin treated extracorporeal circulation circuits (2nd version) - The European working group on heparin coated extracorporeal circulation circuits
    Wildevuur, CRH
    Jansen, PGM
    Bezemer, PD
    Kuik, DJ
    Eijsman, L
    Bruins, P
    DeJong, AP
    VanHardevelt, FWJ
    Biervliet, JD
    Hasenkam, JM
    Kure, HH
    Knudsen, L
    Bellaiche, L
    Ahlburg, P
    Loisance, DY
    Baufreton, C
    LeBesnerais, P
    Bajan, G
    Matta, A
    VanDyck, M
    Renotte, MT
    PonlotLois, A
    Baele, P
    McGovern, EA
    McCarthy, J
    McCarthy, A
    ODonnell, A
    Fosse, E
    Moen, O
    Dregelid, E
    Brockmeier, V
    Anderson, C
    Pomar, JL
    Ranucci, M
    Conti, D
    Cirri, S
    Conti, E
    Ditta, A
    VonSegesser, LK
    Tkebuchava, T
    Weiss, BM
    Turina, MI
    Svennevig, JL
    Mohr, B
    Videm, V
    Karlsen, H
    Pedersen, TH
    Thelin, S
    Halden, E
    Hagman, L
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1997, 11 (04) : 616 - 623
  • [27] Biocompatibility of heparin-coated extracorporeal bypass circuits: New heparin bonded Bioline system
    Tayama, E
    Hayashida, N
    Akasu, K
    Kosuga, T
    Fukunaga, S
    Akashi, H
    Kawara, T
    Aoyagi, S
    ARTIFICIAL ORGANS, 2000, 24 (08) : 618 - 623
  • [28] Haemostasis at low heparin dosage during cardiopulmonary bypass with heparin-coated circuits in pigs
    Bagge, L
    Borowiec, JW
    Thelin, S
    Hultman, J
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 1997, 31 (05) : 275 - 281
  • [29] THROMBOGENICITY OF HEPARIN-COATED AND NON-HEPARIN-COATED CATHETERS - CLINICAL-TRIAL
    KIDO, DK
    PAULIN, S
    ALENGHAT, JA
    WATERNAUX, C
    RILEY, WD
    AMERICAN JOURNAL OF NEURORADIOLOGY, 1982, 3 (05) : 535 - 539
  • [30] THROMBOGENICITY OF HEPARIN-COATED AND NON-HEPARIN-COATED CATHETERS - CLINICAL-TRIAL
    KIDO, DK
    PAULIN, S
    ALENGHAT, JA
    WATERNAUX, C
    RILEY, WD
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1982, 139 (05) : 957 - 961